Matthew Meldorf

Senior Vice President Clinical Development at Attralus Therapeutics

Matthew Meldorf has a diverse work experience in various roles and companies. Matthew is currently working at Attralus as the Senior Vice President of Clinical Development since April 2023. Prior to that, they worked at Genentech where they held multiple positions including Executive Director of Ophthalmology, US Medical Affairs from October 2019 to April 2023. Before that, they were the Senior Group Medical Director of Safety Science from March 2018 to October 2019, Global Franchise Head of Regulatory from October 2015 to March 2018, Regulatory/Global Regulatory Leader from April 2013 to October 2015, and Global Development Team Leader/Clinical Science from November 2010 to April 2013.

Earlier in their career, Matthew also worked at PharmAthene as a Senior Program Director from September 2007 to November 2010, MGI Pharma as the Senior Director of Clinical Research from October 2005 to August 2007, Guilford Pharmaceuticials as the Senior Director of Medical Affairs from 2003 to 2005, and Guilford Pharmaceuticals as the Director of Medical Affairs from 2001 to 2003.

Matthew's earliest work experience was at Greater Baltimore Medical Center as the Associate Program Director for the Internal Medicine Residency Program and Faculty Physician from 1997 to 2001. Matthew started their career as an Acting Clinical Instructor at the Aids Vaccine Evaluation Unit from July 1996 to June 1997.

Matthew Meldorf earned their Bachelor of Arts with Honors in Biology from the University of Chicago in 1989. Matthew then pursued their Doctor of Medicine (M.D.) at The Johns Hopkins University School of Medicine from 1989 to 1993. After completing their medical degree, Matthew Meldorf enrolled in the Internal Medicine Residency Program at the University of California, San Francisco - School of Medicine, where they completed their residency in Internal Medicine from 1993 to 1996. Additionally, in 1987 and 1988, they studied Natural Sciences at Pembroke College, Cambridge University, although it is not specified whether they obtained a degree during this period.

Links

Previous companies

Genentech logo

Org chart

Peers

Timeline

  • Senior Vice President Clinical Development

    April, 2023 - present

View in org chart